Sort   by:  
 Page size 
UnknownHow can we reduce psychological burden for patients of amyotrophic lateral sclerosis and their family caregivers? - Insights from the participatory multi-method study "potentiALS".
Not available
S-EPMC12502389 | biostudies-literature
UnknownTeplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
Not available
S-EPMC3537871 | biostudies-literature
UnknownAntithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.
Not available
S-EPMC6489466 | biostudies-literature
UnknownTargeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
Not available
S-EPMC3957186 | biostudies-literature
UnknownCo-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Not available
S-EPMC3462593 | biostudies-literature
UnknownAntigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Not available
S-EPMC3580128 | biostudies-literature
UnknownA new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
Not available
S-EPMC4302258 | biostudies-literature
UnknownA Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Not available
S-EPMC6105323 | biostudies-literature
UnknownEffect of rituximab on human in vivo antibody immune responses.
Not available
S-EPMC3659395 | biostudies-literature
UnknownInterleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Not available
S-EPMC3827771 | biostudies-literature
Sort   by:  
 Page size